Insulet Corp. Stock Climbs 4.5%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Insulet Corp. rose 4.5% to $139.30 on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.2% to 7,709.96 and Dow Jones Industrial Average falling 0.9% to 53,885.10.

The stock's rise snapped a two-day losing streak.

Insulet Corp. closed 60.7% below its 52-week high of $354.88, which the company reached on November 20th.

The stock outperformed some of its peers, as Eli Lilly & Co. rose 1.9% to $1,191.94, DexCom Inc. rose 0.4% to $83.02, and Johnson & Johnson fell 0.24% to $256.98.

Trading volume totaled 3.2 million, compared to the 50-day average of 1.6 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 06, 2026 16:35 ET (20:35 GMT)